Multi-tier drugs assessment in a decentralised health care system. The Italian case-study
Claudio Jommi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Giovanna Scroccaro(Regione del Veneto), Enrico Costa(Brigham and Women's Hospital), Maria Pisacane(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Alessandra Michelon(Italian Society of Physiotherapy)
Cited by 15
Related Papers
Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study
|Journal of Hepatology|2018|166
Outrageous prices of orphan drugs: a call for collaboration
|The Lancet|2018|160
The impact of FDA and EMA regulatory decision-making process on the access to CFTR modulators for the treatment of cystic fibrosis
|Orphanet Journal of Rare Diseases|2022|51
Efficacy and acceptability of antidepressants on the continuum of depressive experiences in patients with cancer: Systematic review and meta-analysis
|Cancer Treatment Reviews|2015|45
Making hydroxyurea affordable for sickle cell disease in Tanzania is essential (<scp>HASTE</scp>): How to meet major health needs at a reasonable cost
|American Journal of Hematology|2020|31